Penumbra, Inc., the world’s largest thrombectomy company, recently announced the US Food and Drug Administration’s clearance of Lightning Flash 2.0, a next-generation, computer-assisted, vacuum thrombectomy (CAVT) system to remove venous thrombus and treat pulmonary embolism (PE). Lightning Flash 2.0 features advanced Lightning Flash algorithms, designed for increased speed and sensitivity to thrombus and blood flow.
DocWire News spoke with Adam Elsesser, president and CEO of Penumbra, to learn more about this novel system and how it can advance patient care.